Skip to main content
    C

    Cognition Therapeutics Inc (CGTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.64
    -0.04 (-6.03%)

    Market Cap: $64.65M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Cognition Therapeutics Inc (CGTX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Cognition Therapeutics are Cingulate (CING), Gain Therapeutics (GANX) and Coya Therapeutics, Inc. Common Stock (COYA). By market cap, Cognition Therapeutics ranks 8th of the 13 companies on this page; Cassava Sciences (SAVA) is the largest at $114.97M.

    Peer Comparison

    CGTX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Cognition Therapeutics (CGTX)$64.65MN/AN/A0.0%N/A0.0%0.00%
    Cingulate Inc (CING)$62.53MN/AN/A0.0%N/A0.0%0.00%
    Gain Therapeutics Inc (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    Coya Therapeutics, Inc. Common Stock (COYA)$73.42MN/A15.0x0.0%N/A-93.4%0.00%
    Neumora Therapeutics, Inc. (NMRA)$80.59MN/AN/A0.0%-260.5%0.0%0.00%
    Grace Therapeutics, Inc. (GRCE)$38.08MN/AN/A0.0%N/A0.0%0.00%
    Mink Therapeutics Inc (INKT)$47.95MN/A236.3x0.0%N/A0.0%0.00%
    NextCure Inc (NXTC)$29.31MN/AN/A0.0%N/A-100.0%0.00%
    Cassava Sciences Inc (SAVA)$114.97MN/AN/A0.0%N/A0.0%0.00%
    Tenaya Therapeutics Inc (TNYA)$79.59MN/AN/A0.0%N/A0.0%0.00%
    Tiziana Life Sciences Ltd (TLSA)$72.53MN/AN/A0.0%N/A0.0%0.00%
    Tenax Therapeutics Inc (TENX)$73.77MN/AN/A0.0%N/A0.0%0.00%
    vTv Therapeutics Inc (VTVT)$78.99MN/AN/A-20.8%N/A0.0%0.00%
    Peer median$72.97MN/A125.6x0.0%-215.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Cognition Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Cingulate Inc (CING)
    Cingulate Inc., a clinical-stage biopharmaceutical company, is focused on developing candidate products for the treatment of neurobiological and central nervous...
    CING competitors
    Gain Therapeutics Inc (GANX)
    Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding.
    GANX competitors
    Coya Therapeutics, Inc. Common Stock (COYA)
    Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs).
    COYA competitors
    Neumora Therapeutics, Inc. (NMRA)
    Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases...
    NMRA competitors
    Grace Therapeutics, Inc. (GRCE)
    Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
    GRCE competitors
    Mink Therapeutics Inc (INKT)
    MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic...
    INKT competitors
    NextCure Inc (NXTC)
    NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other...
    NXTC competitors
    Cassava Sciences Inc (SAVA)
    Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.
    Tenaya Therapeutics Inc (TNYA)
    Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary...
    TNYA competitors
    Tiziana Life Sciences Ltd (TLSA)
    Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat...
    Tenax Therapeutics Inc (TENX)
    Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing...
    TENX competitors
    vTv Therapeutics Inc (VTVT)
    vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet...
    VTVT competitors

    Frequently Asked Questions About CGTX

    Who are Cognition Therapeutics' main competitors?

    The companies most similar to Cognition Therapeutics include Cingulate (CING), Gain Therapeutics (GANX), Coya Therapeutics, Inc. Common Stock (COYA), Neumora Therapeutics (NMRA) and Grace Therapeutics (GRCE), listed from the closest match.

    Who is Cognition Therapeutics' biggest competitor?

    Cassava Sciences (SAVA) is the largest of the similar companies at $114.97M; Cingulate (CING) is the closest match by business profile, size, sector and industry.

    How does CGTX stock compare with its competitors?

    CGTX's net margin is 0.0% against a peer median of 0.0%.

    Which of Cognition Therapeutics' competitors pays a higher dividend?

    Cognition Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Cognition Therapeutics bigger than its competitors?

    No. Cognition Therapeutics is 8th by market cap among the 13 companies on this page; the largest is Cassava Sciences (SAVA) at $114.97M.